BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 31, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Washington roundup: Delivery system talk leaves Senate committee in quandary

May 6, 2009
By Mark McCarty
WASHINGTON – The Senate Finance Committee held the second of three open forums on healthcare reform yesterday, and the session began with more enthusiasm than is typical of such gatherings. The fact that none of the witnesses called to testify were advocates of a single-payer system was not missed by the idea's supporters, who complained loudly and out of turn about the omission as the session commenced. (Medical Device Daily)
Read More

Washington roundup: Senate brings back Drug and Device Accountability Act

May 5, 2009
By Mark McCarty

Market Developments: Sebelius, DeParle win acclaim as nominees for key health posts

May 1, 2009
By Mark McCarty

Fraud is a persistent problem that is in need of more effort

May 1, 2009
By Mark McCarty

House Judiciary sending mixed signals on damages language

May 1, 2009
By Mark McCarty
WASHINGTON – The House Judiciary Committee finally held a hearing on the Patent Reform Act of 2009 (H.R. 1260), but readers of tea leaves might have left the hearing unsure as to where the committee stands on several key issues, including provisions dealing with how juries should calculate damages in infringement lawsuits. (Medical Device Daily)
Read More

Market Developments: Naming of Sebelius, DeParle for healthcare posts gains acclaim

May 1, 2009
By Mark McCarty

Washington roundup: Sebelius in at HHS, Specter parts ways with reeling GOP

April 30, 2009
By Mark McCarty
The Obama administration finally has a full cabinet, thanks to the Tuesday Senate vote that came in at 65-31 to confirm Gov. Kathleen Sebelius (D-Kansas) to the position of Secretary of Health and Human Services, but the White House scored again when Sen. Arlen Specter (D-Pennsylvania) checked his GOP card at the door and defected to the Democratic Party. (Medical Device Daily)
Read More

HIT: Healthcare InfoTech Business Report – Infrastructure is essential to making HIT data useful

April 29, 2009
By Mark McCarty

HIT: Healthcare InfoTech Business Report – Washington roundup: Baucus says reform bill to be ready for Senate by June

April 29, 2009
By Mark McCarty

IOM conflict report liable to fall on deaf ears on Hill

April 29, 2009
By Mark McCarty
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 30, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing